Vasoactive compounds in the neonatal period

Current Medicinal Chemistry

Volumn 19, Issue 27, 2012, Pages 4633-4639

  Toth Heyn, P ^a   Cataldi, L ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Catecholamine; Dopamine; Hypotension; Neonate; Shock; Vasoactive drug

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; HYDROCORTISONE; ISOPRENALINE; LEVOSIMENDAN; METHYLENE BLUE; MILRINONE; NORADRENALIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN; CATECHOLAMINE; CORTICOSTEROID; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT; VASOPRESSIN DERIVATIVE;

ADRENERGIC ACTIVITY; AGE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; ELEVATED BLOOD PRESSURE; FORWARD HEART FAILURE; GLOMERULUS FILTRATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; HYPOTENSION; INOTROPISM; MICROCIRCULATION; NEWBORN PERIOD; PULMONARY HYPERTENSION; SHOCK; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; VASOCONSTRICTION; VASODILATATION; CARDIOVASCULAR SYSTEM; DRUG EFFECT; NEWBORN; REVIEW;

ADRENAL CORTEX HORMONES; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; HUMANS; HYDRAZONES; HYPOTENSION; INFANT, NEWBORN; MILRINONE; PYRIDAZINES; VASODILATOR AGENTS; VASOPRESSINS;

EID: 84875279502     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803306330     Document Type: Article

References (83)

1. Al-Aweel I., Pursley D.M., Rubin L.P., Shah B., Weisberger S., Richardson D.K. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol, 2001, 21:272-278.
2. Kluckow M., Evans N.J. The relationship between cardiac output and blood pressure in preterm infants requiring mechanical ventilation. J Pediatr, 1996, 129,506-512.
3. Kent A.L., Kecskes Zs., Shadbolt B., Falk M.C. Normative blood pressure data in the early neonatal period Pediatr Nephrol, 2007, 22:1335-1341.
4. Kent A.L., Meskell S., Falk M.C., Shadbolt B. Normative blood pressure data in non-ventilated premature neonates from 28-36 weeks gestation. Pediatr Nephrol, 2009, 24:141-146.
5. Seri I. Management of hypotension and low systemic blood flow in the very low birth weight neonate during the first postnatal week. J Perinatol, 2006, 26, S8-S13.
6. Wynn J.L.; Wong H.R.; Pathophysiology and treatment of septic shock in neonates. Clin Perinatol, 2010, 37, 439-479.
7. Barrington K.J. Hypotension and shock in the preterm infant. Seminars in Fetal and Neonatal Medicine, 2008, 13, 16-23.
8. Greisen G. Autoregulation of cerebral blood flow in newborn babies. Early Hum Dev, 2005, 81,423-428.
9. Lightburn M.H., Gauss C.H., Williams D.K., Kaiser J.R. Cerebral blood flow velocities in extremely low birth weight infants with hypotension and infants with normal blood pressure. J Pediatr, 2009, 154,824-828.
10. Toth-Heyn P., Drukker A., Guignard J.P. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol, 2000, 14,227-239.
11. Guignard J-P., Burgener F., Calame A. Persistent anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol, 1981, 2: 133
12. Smith F.G., Nohara N., Patel A., Sener A. Endothelin-1 produces no renal vasoconstriction in conscious newborn lambs. Pediatr Nephro, 2002, 17,889-895.
13. Nakwan N., Choksuchat D., Saksawad R., Thammachote P., Nakwan N. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. Acta Paediatr, 2009, 98,1683-1685.
14. Toth-Heyn P., Guignard J.P. Endogenous bradykinin regulates renal function in the newborn rabbit. Biol Neonate, 1998, 73,330-336.
15. Solhaug M.J., Wallace M.R., Granger J.P. Endothelium-derived nitric oxide modulates renal hemodynamics in the developing piglet. Pediatr Res, 1993, 34:750-754.
16. Evans N. Which inotrope for which baby? Arch Dis Child Fetal Neonatal Ed, 2006, 91, F213-220.
17. Pearson RJ, Barrington KJ, Jirsch DW, Cheung PY. Dopaminergic receptormediated effects in the mesenteric vasculature and renal vasculature of the chronically instrumented newborn piglet. Crit Care Med, 1996, 24,1706-1712.
18. Seri I., Tulassay T., Kiszel J., Ruppert F., Sulyok E., Ertl T., Bódis J., Csömör S. Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease. Biol Neonate, 1985, 47,317-322.
19. Filippi L., Pezzati M., Poggi C., Rossi S., Cecchi A., Santoro C. Dopamine versus dobutamine in very low birthweight infants: endocrine effects. Arch Dis Child Fetal Neonatal Ed, 2007, 92,F367-71.
20. Cheung P.Y., Barrington K.J., Bigam D. The hemodynamic effects of dobutamine infusion in the chronically instrumented newborn piglet. Crit Care Med, 1999, 27,558-564.
21. Driscoll D.J. Use of inotropic and chronotropic agents in neonates. Clin Perinatol, 1987, 14:931-949.
22. Rozé J.C., Tohier C., Maingueneau C., Lefèvre M., Mouzard A. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child, 1993, 69(1 Spec No),59-63.
23. Osborn D.A., Evans N., Kluckow M. Left ventricular contractility in extremely premature infants in the first day and response to inotropes. Pediatr Res, 2007, 61,335-340.
24. Greenough A., Emery E.F. Randomized trial comparing dopamine and dobutamine in preterm infants. Eur J Pediatr, 1993, 152,925-927.
25. Klarr J.M., Faix R.G., Pryce C.J., Bhatt-Mehta V. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr, 1994, 125,117-22.
26. Osborn D., Evans N., Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr, 2002, 140,183-191.
27. Pellicer A., Valverde E., Elorza M.D., Madero R., Gayá F., Quero J., Cabañas F. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics, 2005, 115,1501-1512.
28. Valverde E., Pellicer A., Madero R., Elorza D., Quero J., Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics, 2006, 117,e1213-1222.
29. Lundstrøm K., Pryds O., Greisen G. The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev, 2000, 57,157-163.
30. Sassano-Higgins S., Friedlich P., Seri I. A meta-analysis of dopamine use in hypotensive preterm infants: blood pressure and cerebral hemodynamics. J Perinatol, 2011, Jan 27. [Epub ahead of print]
31. Osborn D.A., Evans N., Kluckow M., Bowen J.R., Rieger I. Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants. Pediatrics, 2007, 120,372-380.
32. Pellicer A., Bravo M.C., Madero R., Salas S., Quero J., Cabañas F. Early systemic hypotension and vasopressor support in low birth weight infants: impact on neurodevelopment. Pediatrics, 2009, 123,1369-1376.
33. Osborn D.A., Paradisis M., Evans N. The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow. Cochrane Database Syst Rev, 2007, 24,(1),CD005090.
34. Seri I., Tan R., Evans J. The effect of hydrocortisone on blood pressure in preterm neonates with vasopressor-resistant hypotension. Pediatrics, 2001, 107, 1070-1074.
35. Noori S., Friedlich P., Wong P., Ebrahimi M., Siassi B., Seri I. Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates. Pediatrics, 2006, 118, 1456-1466.
36. American Academy of Pediatrics, Committee on Fetus and Newborn, Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002, 109, 330-338
37. Colucci W.S. Cardiovascular effects of milrinone. Am Heart J, 1991, 121,1945-1947.
38. Barton P., Garcia J., Kouatli A., Kitchen L., Zorka A., Lindsay C., Lawless S., Giroir B. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest, 1996, 109,1302-1312.
39. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., Bailey J.M., Akbary A., Kocsis J.F., Kaczmarek R., Spray T.L., Wessel D.L. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation, 2003, 107,996-1002.
40. Barrington K.J, Dempsey E.M. Cardiovascular support in the preterm: treatments in search of indications. J Pediatr, 2006, 148,289-291.
41. Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr, 2009, 154,189-195.
42. Toyoshima K., Momma K., Imamura S., Nakanishi T. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate, 2006, 89,251-256.
43. Chang A.C., Atz A.M., Wernovsky G., Burke R.P., Wessel D.L. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med, 1995, 23,1907-1914.
44. Sehgal A., Francis J.V., Lewis A.I. Use of milrinone in the management of haemodynamic instability following duct ligation. Eur J Pediatr, 2011, 170,115-119.
45. Paradisis M., Jiang X., McLachlan A.J., Evans N., Kluckow M., Osborn D. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed, 2007, 92,F204-209.
46. Zuppa A.F., Nicolson S.C., Adamson P.C., Wernovsky G., Mondick J.T., Burnham N., Hoffman T.M., Gaynor J.W., Davis L.A., Greeley W.J., Spray T.L., Barrett J.S. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction.,Anesth Analg, 2006, 102,1062-1069.
47. Sehgal A. Haemodynamically unstable preterm infant: an unresolved management conundrum. Eur J Pediatr, 2011, DOI 10.1007/s00431-011-1435-4
48. Landry D.W., Levin H.R., Gallant E.M., Ashton R.C. Jr, Seo S., D'Alessandro D., Oz M.C., Oliver J.A. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 1997, 95: 1122-1125.
49. Bauer S.R., Lam S.W. Arginine vasopressin for the treatment of septic shock in adults. Pharmacotherapy, 2010, 30, 1057-1071.
50. Lodha R., Vivekanandhan S., Sarthi M., Kabra S.K. Serial circulating vasopressin levels in children with septic shock. Ped Crit Care Med, 2006, 7,220-224.
51. Leclerc F., Walter-Nicolet E., Leteurtre S., Noizet O., Sadik A., Cremer R., Fourier C. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med, 2003 29,1339-1344.
52. Meyer S., Gortner L., McGuire W., Baghai A., Gottschling S. Vasopressin in catecholamine-refractory shock in children. Anaesthesia, 2008, 63, 228-234.
53. Lechner E., Hofer A., Mair R., Moosbauer W., Sames-Dolcer E., Tulzer G. Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr, 2007, 166,1221-1227.
54. Matok I., Leibovitsch L., Vardi A., Adam M., Rubinshtein M., Barzilay Z., Paret G. Terlipressin as a rescue therapy for intractable hypotension during neonatal spetic shock. Pediatr Crit Care Med, 2004, 5, 116-118.
55. Filippi L., Poggi C., Serafinin L., Fiorini P. Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatrica, 2008, 97, 500-553
56. Filippi L., Gozzini E., Daniotti M., Pagliai F., Catarzi S., Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med, 2010
57. Brierley J., Carcillo J.A., Choong K., Cornell T., Decaen A., Deymann A., Doctor A., Davis A., Duff J., Dugas M.A., Duncan A., Evans B., Feldman J., Felmet K., Fisher G., Frankel L., Jeffries H., Greenwald B., Gutierrez J., Hall M., Han Y.Y., Hanson J., Hazelzet J., Hernan L., Kiff J., Kissoon N., Kon A., Irazuzta J., Lin J., Lorts A., Mariscalco M., Mehta R., Nadel S., Nguyen T., Nicholson C., Peters M., Okhuysen-Cawley R., Poulton T., Relves M., Rodriguez A., Rozenfeld R., Schnitzler E., Shanley T., Kache S., Skippen P., Torres A., von Dessauer B., Weingarten J., Yeh T., Zaritsky A., Stojadinovic B., Zimmerman J., Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med, 2009, 37,666-688.
58. Malay M.B., Ashton J.L., Dahl K., Savage E.B., Burchell S.A., Ashton R.C. Jr, Sciacca R.R., Oliver J.A., Landry D.W. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med, 2004, 32,1327-1331.
59. Kampmeier T. G., Rehberg S., Westphal M., Lange M. Vasopressin in sepsis and septic shock. Minerva Anestesiologica, 2010, 76,844-850.
60. Willems MG., Schoenemann J., Rey C., Schäfer H., Lindecken K.D. Ischemia of the cecum caused by glycylpressin. Leber Magen Darm. 1985 Jul;15(4):165-8.
61. Schmitt W., Wagner-Thiessen E., Lux G. Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices. Hepatogastroenterology, 1987, 34,134-136.
62. Frank E., Landgraf R. The vasopressin system-from antidiuresis to psychopathology. Eur J Pharmacol, 2008, 583:226-242.
63. Tribollet E., Goumaz M., Raggenbass M., Dubois-Dauphin M., Dreifuss J.J. Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Brain Res Dev Brain Res, 1991, 58,13-24.
64. Winslow J.T., Insel T.R. Effects of central vasopressin administration to infant rats. Eur J Pharmacol, 1993, 233,101-107
65. De Luca L., Colucci W.S., Nieminen M.S., Massie B.M., Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. European Heart Journal, 2006, 27,1908-1920.
66. Kivikko M., Lehtonen L., Colucci W.S. Sustained haemodynamic effects of intravenous levosimendan. Circulation, 2003, 107:81-86.
67. Turanlahti M., Boldt T., Palkama T., Antila S., Lehtonen L., Pesonen E. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med, 2004, 5,457-462.
68. Braun JP, Schneider M, Kastrup M, Liu J. Treatment of acute heart failure in an infant after cardiac surgery using levosimendan. Eur J Cardiothorac Surg, 2004, 26,228-230.
69. Egan J.R., Clarke A.J., Williams S., Cole A.D., Ayer J., Jacobe S., Chard R.B., Winlaw D.S. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med, 2006, 21,183-187.
70. Osthaus W.A., Boethig D., Winterhalter M., Huber D., Goerler H., Sasse M., Sümpelmann R. First experiences with intraoperative Levosimendan in pediatric cardiac surgery. Eur J Pediatr, 2009, 168,735-740.
71. Lechner E., Moosbauer W., Pinter M., Mair R., Tulzer G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med, 2007, 8,61-63.
72. Namachivayam P., Crossland D.S., Butt W.W., Shekerdemian L.S. Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med, 2006, 7,445-448.
73. Di Chiara L., Ricci Z., Garisto C., Morelli S., Giorni C., Vitale V., Di Donato R.M., Picardo S. Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome. Pediatr Cardiol, 2010, 31,166-167.
74. Endoh M. Cardiac Ca2+ signaling and Ca2+ sensitizers. Circ J, 2008, 72, 1915-1925.
75. Hoffman T.M. Newer Inotropes in Pediatric Heart Failure. J Cardiovasc Pharmacol, 2011, 58:121-125.
76. Preiser J.C., Lejeune P., Roman A., Carlier E., De Backer D., Leeman M., Kahn R.J., Vincent J.L. Methylene blue administration in septic shock. a clinical trial. Crit Care Med 1995, 23:259-264.
77. Shi Y., Li H.Q., Shen C.K., Wang J.H., Qin S.W., Liu R., Pan J. Plasma nitric oxide levels in newborn infants with sepsis. J Pediat,. 1993, 123:435-438.
78. Driscoll W., Thurin S., Carrion V., Steinhorn R., Morin F. Effect of methylene blue on refractory neonatal hypotension. J Pediatr, 1996, 129:904-908
79. Smith G.W., O'Connor S.E. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride). Am J Cardiol, 1988, 62:9C-17C.
80. Thomas T.V., Mace T.P., Choe E.U., Flint L.M., Ferrara J.J. Dopexamine maintains mesenteric blood flow during systemic hypoxemia int he neonatal piglet. J Gastrointest Surg, 1997, 1:362-369.
81. Jaton T., Thonney M., Gouyon J.B., Guignard J.P. Renal effects of dopamine and dopexamine int he newborn anesthetized rabbit. Life Sci, 1992, 50:195-202.
82. Kawczynski P., Piotrowski A. Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure. Intensive Care Med, 1996, 22:65-70.
83. Booker P.D., Pozzi M. A placebo-controlled study of the effects of dopexamine on gastric mucosal perfusion in infants undergoing hypothermic cardiopulmonary bypass. Br J Anaesth, 2000, 84:23-27.